freeze dried acerola_freeze dried acerola

Knee OA is the leading cause of disability and pain among adult and old age populations. An estimated 10 to 15% of all adults older than 60 years have some degree of OA, with prevalence higher among women than men.

Number of exhibitors: 1300+

Coronavirus has dramatically increased U.S. consumer demand in many dietary supplements, whether it is for improved nutrition during the crisis, assistance with sleep and stress relief, or supporting a strong immune function to improve general resistance to health threats.

On this occasion, As a memeber of qualified botanical extract suppliers, It’s a great pleasure gathering with many industry senior elites, cooperating with this worthy undertaking.

Vitafoods Europe is the most influential exhibition of nutritional health products and functional foods in Europe. The global nutraceutical supply chain comes together to provide a perfect platform for creating new business and establishing profitable relationships, and is the only professional covering four key areas from raw materials and raw materials, branded finished products, OEM and private label, service and equipment Activity. Various conference events are held during Vitafoods Europe in Geneva, Switzerland, providing visitors with an opportunity to learn new things and network. is where nutrition experts create innovations, shape the future of the industry, find effective solutions to future problems, and connect with business leaders. With the vigorous development of nutraceuticals and food, Vitafoods Europe, Geneva Health Food and Raw Materials Exhibition, has gone through years of market testing and has taken the leading position in emerging markets.

Knee arthritis symptoms of pain, joint stiffness, and diminished physical function were evaluated using the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC). After six weeks of treatment, responder analysis showed significant improvement in WOMAC scores across all parameters comparable to the paracetamol group, with 18% of the BCM-95 group reporting 50% improvement, and 3% of subjects noting 70% improvement.